Federal prosecutors in Oregon have charged two Pakistani nationals with running separate healthcare fraud schemes that allegedly bilked Medicare and other government programs out of up to $17 million, part of a sweeping nationwide crackdown that has now netted 455 defendants accused of more than $6.5 billion in false claims.

Jahangeer Ali, 34, owner of Oregon Clinical Laboratory, allegedly submitted fraudulent genetic testing claims to Medicare Advantage plans totaling up to $15 million. Mehrdad Gerami, 67, allegedly fabricated sleep study results through Coastal Diagnostic Testing Group and Coastal Diagnostic offices. Both were arrested in the District of Oregon.

The charges land as the Trump administration continues an aggressive push to root out healthcare fraud across the country, an effort that has already suspended or revoked billing privileges for thousands of providers and triggered billions in potential recovery actions.

The Oregon schemes: fake tests, phantom clinics

The case against Ali is built on a straightforward allegation: he billed Medicare Advantage plans for genetic tests that were never legitimately ordered. Federal investigators found that doctors and clinics named in Ali's billing statements told them they had no dealings with his company. The alleged cost to taxpayers: up to $15 million funneled through a single laboratory.

Gerami's alleged operation worked a different angle. He claimed sleep studies were conducted at his Coastal Diagnostic facilities when, federal officials say, those studies were either performed somewhere else entirely or never conducted at all. The combined alleged fraud between the two defendants reaches $17 million, though the specific dollar figure attributed to Gerami's scheme alone has not been disclosed.

Neither defendant's plea status has been made public. The maximum penalties they face remain unspecified in available federal filings.

A $6.5 billion enforcement wave

The Oregon arrests are a small piece of a far larger operation. Nationwide, 455 defendants, including 90 doctors and other licensed medical professionals, face charges in what federal officials describe as a major healthcare fraud enforcement action. The total alleged false claims exceed $6.5 billion.

The scale of the administrative response is equally striking. The Centers for Medicare and Medicaid Services suspended 1,079 providers and revoked billing privileges for another 1,403. The HHS Office of Inspector General carried out more than 1,400 provider exclusions and reached 48 civil monetary payment settlements totaling over $73 million.

The administration has made clear it views healthcare fraud not as a bookkeeping problem but as theft from the most vulnerable. The appointment of Vice President Vance as fraud czar earlier this year signaled that enforcement would be centralized and relentless.

HHS-OIG also filed 25 actions under the Civil Monetary Penalties Law seeking more than $10 billion in payments to the Medicare Trust Fund. Civil charges hit 13 additional defendants for $14.8 million in fraud schemes, and 31 defendants reached civil settlements totaling $23 million.

The Drug Enforcement Administration, meanwhile, filed 928 administrative cases seeking to revoke authority to handle or prescribe controlled substances, a parallel track targeting providers who exploit prescribing privileges.

New fraud division leads the charge

Much of this enforcement flows through the DOJ's National Fraud Enforcement Division, launched on April 7. The new unit was designed to coordinate federal prosecutors, inspectors general, and regulatory agencies across jurisdictions, exactly the kind of multi-agency cooperation on display in the Oregon case.

U.S. Attorney Scott E. Bradford of the District of Oregon framed the stakes plainly in a statement announcing the charges:

"Health care fraud inflates costs, restricts access to critical services, and siphons taxpayer dollars from senior citizens, people with disabilities, low-income families, veterans, and others who rely on these federal programs. Strong coordination among local, state, national, and international partners is essential to protecting the integrity of our health care system and ensuring those who exploit it are held accountable."

That last phrase, "those who exploit it", describes a category of defendant that federal investigators have found in growing numbers. The breadth of the current enforcement action suggests the problem is systemic, not isolated.

The fraud doesn't just drain federal coffers. It corrodes the programs that millions of Americans depend on. Allegations of widespread phantom enrollments in Obamacare have raised similar concerns about the integrity of federal health programs across the board.

Veterans programs targeted too

The Oregon case is notable for the range of programs allegedly victimized. Beyond Medicare, the defendants are accused of defrauding the Department of Health and Human Services, the Veterans Health Administration, and private insurers. The involvement of the VA makes the case personal for millions of veterans who rely on those benefits.

Special Agent in Charge Dimitriana Nikolov of the VA OIG's Western Pacific Field Office put it in direct terms:

"Every dollar saved by investigating fraud helps ensure VA programs remain sustainable for the veterans who depend on them. The VA OIG is committed to investigating those who exploit VA programs and thanks the U.S. Attorney's Office and Department of Health and Human Services Office of Inspector General for their collaboration to identify, investigate, and eliminate waste, fraud, and abuse."

When someone bills the VA for services never rendered, the cost isn't abstract. It means fewer resources for the men and women who served. That reality gives these prosecutions a moral weight beyond the dollar figures.

The broader fraud crackdown has hit particularly hard in states where oversight has lagged. In California, the Vance-led fraud task force suspended nearly 450 hospice providers over $600 million in suspect claims, a staggering figure from a single state and a single category of care.

Accountability gaps remain

Several questions about the Oregon case remain unanswered. The specific statutes under which Ali and Gerami were charged have not been disclosed publicly. The private insurance companies allegedly defrauded have not been named. And the immigration status of both defendants beyond their description as Pakistani nationals is unclear from available federal records.

What is clear is the pattern. Fraudsters set up shell operations, bill government programs for services never provided, and count on the sheer volume of claims to avoid detection. Ali allegedly ran his scheme through a single laboratory. Gerami allegedly fabricated results and attributed them to his own facilities. Both bet that no one would check.

Federal investigators checked.

The enforcement action also raises broader questions about how these schemes operate for so long before detection. A $15 million billing stream from a single laboratory should trigger automated flags. Whether CMS and Medicare Advantage plans had adequate fraud-detection systems in place, and whether those systems failed, deserves scrutiny. A federal judge recently sided with the Trump administration's Medicaid freeze in Minnesota, citing the state's own fraud record as justification, a sign that courts are taking the scale of the problem seriously.

The bigger picture

Healthcare fraud has festered in the federal system for decades. Estimates of annual losses range into the tens of billions. Past administrations talked about the problem. This one has built a dedicated enforcement division, empowered inspectors general across agencies, and produced a single enforcement action covering 455 defendants and $6.5 billion in alleged false claims.

The Oregon case, with its $17 million in alleged fraud, is modest by comparison. But it illustrates the mechanics: a laboratory owner billing for tests that clinics say they never ordered, a diagnostics operator fabricating results for studies that never happened. These are not billing errors. They are, if the charges hold, deliberate schemes to steal from programs designed to help the sick, the elderly, and those who served their country.

Fraud referrals have reached the highest levels of state government in recent months, a reminder that the rot extends well beyond individual clinics and laboratories.

Every dollar stolen from Medicare is a dollar that doesn't reach a senior citizen's hospital bed. Every fake VA claim is a betrayal of someone who wore the uniform. If the federal government can't protect those programs from fraud, it has failed at one of its most basic obligations.

The charges are filed. Now the system has to finish the job.